GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.07 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.14 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +1.90%. A quarter ago, it was expected that this medical technology company would post earnings of $0.91 per share when it actually produced earnings of $1.06, delivering a surprise of +16.48%.Over the l ...

3Q 2025 Earnings Presentation October 29, 2025 © 2025 GE HealthCare. GE is a trademark of General Electric Company used under trademark license. Forward-looking statements and additional information This presentation contains forward-looking statements. These forward-looking statements might be identified by words, and variations of words, such as "will," "expect," "may," "would," "could," "plan," "believe," "anticipate," "intend," "estimate," "potential," "position," "forecast," "target," "guidance," "outl ...

GE HealthCare Technologies raised its annual adjusted profit forecast and beat estimates for third-quarter results on Wednesday, powered by strong demand for its medical devices in the United States a... ...

GE HealthCare Technologies' said profit fell in the third quarter, weighed down by the added costs of tariffs. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission file number 001-41528 GE HEALTHCARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter) | Delaware | 88-25151 ...

Exhibit 99 GE HealthCare reports third quarter 2025 financial results Chicago, IL – October 29, 2025 – GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2025. GE HealthCare President and CEO Peter Arduini said, "We delivered robust orders with growth across all segments in the third quarter. This was led by customer demand for our differentiated solutions and a healthy capital equipment environment. Revenue performance was driven by Imaging, Advanced Vis ...

Oct 29, 2025 6:20 AM Eastern Daylight Time GE HealthCare reports third quarter 2025 financial results Share CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2025. GE HealthCare President and CEO Peter Arduini said, "We delivered robust orders with growth across all segments in the third quarter. This was led by customer demand for our differentiated solutions and a healthy capital equipment environment. Revenue performance was ...

文章核心观点 - 消费技术、动态监测和传统医疗系统的融合正在重新定义心脏护理的未来，而知识产权的控制权将决定哪些公司引领下一个诊断时代 [1][4] - 一个价值1330亿美元的全球市场机会正在推动将医院级诊断技术引入便携式、互联和消费者可及系统的努力 [2] 心脏诊断技术市场现状 - 心血管疾病是全球主要死亡原因，占美国死亡人数的四分之一 [2] - 诊断金标准12导联心电图近一个世纪来主要局限于医院内使用 [2] - 当前消费级可穿戴设备的心率追踪和单导联心电图功能仅局限于心律筛查，无法检测缺血或复制12导联诊断的准确性 [7] 主要参与者与技术分析 - 报告分析了包括苹果、三星、谷歌/Fitbit、Oura、Whoop等领先消费和医疗技术公司的技术、产品和专利组合 [4] - 传统设备制造商如飞利浦、GE Healthcare正受到包括HeartBeam、AliveCor、梅奥诊所等新兴创新者的挑战 [7] - HeartBeam公司成为首个实现无线12导联心电图技术，复制了诊断金标准 [7] 知识产权格局 - 分析涵盖了243个组织的581个专利家族 [4][7] - 消费可穿戴公司的知识产权活动集中在用于心率和基本心律失常检测的单导联心电图，而非全面诊断能力 [7] - 动态监测公司正在开发超越心律追踪、迈向诊断级性能的便携系统 [7]

Key Takeaways GEHC Q3 revenues are estimated at $5.07B, up 4.2% year over year, with EPS of $1.05.GEHC's Imaging and Pharmaceutical Diagnostics likely offset weakness in Patient Care Solutions.Tariff costs are expected to pressure GEHC's margins, driving a high-single-digit EBITDA decline.GE HealthCare Technologies Inc. (GEHC) is scheduled to report third-quarter 2025 results on Oct. 29, before market open.In the last reported quarter, the company’s adjusted earnings per share (EPS) of $1.06 surpassed the Z ...

公司历史与转型 - 公司由托马斯·爱迪生于1892年创立，拥有超过133年历史，以创新著称 [1] - 公司历史上在多个技术领域进行创新，包括水电、航空、能源电网、风能、医疗保健和材料科学 [2] - 因过度多元化、业务战略失败及涉足金融服务业遭遇重大挫折，股价在2007年至2009年间暴跌超过80% [3] - 原通用电气公司自2021年起分拆为三家独立上市公司：GE Aerospace、GE Vernova和GE HealthCare Technologies [4] 分拆后公司表现 - GE Aerospace在过去五年股价表现最佳，累计上涨727%，GE Vernova上涨417%，GE HealthCare上涨约20% [5] - GE Aerospace是原公司分拆后留存的主体，专注于生产喷气发动机和涡轮螺旋桨发动机等航空部件 [5][7] - GE Aerospace目前市值约为3210亿美元，去年营收超过350亿美元 [6] 近期财务与运营业绩 - 公司第三季度调整后营收增长26%至113亿美元，每股收益增长44%至1.66美元，远超华尔街预期 [8] - 第三季度新订单增长5%至103亿美元，国防收入大幅增长26% [8] - 公司预计今年营收将增长约16%至近410亿美元 [6] 行业与市场状况 - 航空制造业面临瓶颈和供应链问题，这为GE Aerospace创造了有利的运营环境 [5] - 公司股票当前交易价格约为过去盈利的7倍 [6]